Author response: Assessment and effect of a gap between new-onset epilepsy diagnosis and treatment in the US

Neurology ◽  
2020 ◽  
Vol 94 (11) ◽  
pp. 503-503
Author(s):  
Linda Kalilani ◽  
Edward Faught ◽  
David Thurman ◽  
Hyunmi Kim
2019 ◽  
Vol 229 (4) ◽  
pp. S149-S150
Author(s):  
Katherine Wu ◽  
Stephanie G. Worrell ◽  
Katelynn Bachman ◽  
Vanessa P. Ho ◽  
Yaron Perry ◽  
...  

2020 ◽  
Author(s):  
Benyamin Rotberg ◽  
Erzsébet Horváth‐Puhó ◽  
Simone Vigod ◽  
Joel G. Ray ◽  
Henrik Toft Sørensen ◽  
...  

2020 ◽  
Author(s):  
Ken‐ichi Nagakura ◽  
Sakura Sato ◽  
Tomoyuki Asaumi ◽  
Noriyuki Yanagida ◽  
Motohiro Ebisawa

1995 ◽  
Vol 41 (10) ◽  
pp. 1434-1438 ◽  
Author(s):  
M D Marshall ◽  
S N Kales ◽  
D C Christiani ◽  
R H Goldman

Abstract CO is a leading cause of poisoning deaths in the US today. Treating physicians use the carboxyhemoglobin (COHb) % saturation to guide the diagnosis and treatment of CO intoxication. We conducted a telephone survey of hospitals and laboratories in the Boston area, focusing on methodology for COHb determination and accompanying COHb reference intervals. Among 130 facilities, 23 (18%) provide COHb analysis. All facilities that perform the COHb test utilize dedicated multiwave-length photometry. Reference intervals for COHb varied widely among facilities. Eight of 21 (38%) facilities give unacceptably high "normal intervals" for nonsmokers when compared with values available in the literature. Thirteen of 20 (65%) use reference intervals for smokers that are too low, and 3 of 20 (15%) use values that are too high. These reference values provided by the testing facilities may be misleading to the ordering physicians unfamiliar with background COHb saturations. This may lead to misdiagnoses, false reassurances, and perhaps less aggressive treatment than might be warranted. The results of this study argue for wider adoption of COHb reference intervals supported by the current literature.


Author(s):  
Luke Cielonko ◽  
Tyler Hamby ◽  
John S. Dallas ◽  
Luke Hamilton ◽  
Don P. Wilson

AbstractBackground:Early diagnosis and expeditious treatment of newborns with congenital hypothyroidism (CH) is necessary to avoid mental retardation.Methods:A survey of 44 practitioners in the southern US was conducted to better understand common practices regarding neonatal CH and the findings were compared with current guidelines in the US and Europe.Results:Responses indicated some consensus that 10–15 μg of thyroid hormone/kg/day was the appropriate dosage. However, despite guidelines advocating their use, practitioners reported that they did not commonly use imaging or laboratory tests, though experienced providers apparently used them more often.Conclusions:Together, these results show moderate adherence to published guidelines for treating and diagnosing CH. Further research is needed to determine why providers deviate from these guidelines and to generalize these results to other populations.


Sign in / Sign up

Export Citation Format

Share Document